Author: AdminTNC

  • It could’ve been worse: White House debt meeting ends with plans for a repeat

    It could’ve been worse: White House debt meeting ends with plans for a repeat

    [ad_1]

    aptopix biden 95134

    Aides to the four party leaders in each chamber of Congress and White House staff will continue talks during the week, McCarthy said, and the players will convene again on Friday. Democratic leaders said separately that party leaders would begin discussing a possible budget and spending deal as soon as Tuesday evening — a step closer to pairing the debt limit with another major headache for party leaders.

    Yet neither party’s leaders even edged away from their entrenched positions on the debt limit: Biden and Senate Majority Leader Chuck Schumer said there’s nothing to negotiate. And McCarthy dinged Biden for being unable to articulate any spending cut he might consider as part of a deal to increase the Treasury Department’s borrowing power.

    Instead, the speaker reiterated that the House is the only chamber that has passed a bill dealing with the topic — a measure packed with conservative priorities that Biden’s party has rejected.

    Biden actually went further after the meeting, saying he was “considering” the use of the 14th amendment as a means to circumvent the debt ceiling standoff. But he cast some doubt on whether it could work, saying it would “have to be litigated, and in the meantime without an extension it’d still end up in the same place.”

    Deal-making senators in both parties, however, appeared irked by the lack of progress. Sen. Joe Manchin (D-W.Va.), who met with McCarthy himself and pressed Biden to negotiate, said he expected more.

    “To have five of the political leaders for our country walk out of the meeting and not one of them say that we made progress?” Manchin said. “Ridiculous.”

    Sen. Bill Cassidy (R-La.) said that whether the country defaults or not depends largely on Biden saving the day: “If the president shows leadership, I don’t think we’re going to default. If the president just kind of sits there and, you know, repeats the same thing over and over again, we’ve got an issue.”

    Despite that bleak result, Tuesday’s meeting ended as positively as anyone could have hoped for with a possible debt ceiling breach potentially a month or less away. After near-total silence since February between Biden and McCarthy, the two main negotiating partners, the duo is now set to meet twice in one week.

    As McCarthy returned to the Capitol after a week-long recess on Tuesday, the California Republican declared that party leaders should nail down the outlines of a deal in the next two weeks to ensure the U.S. doesn’t go careening off a fiscal cliff.

    “We now have just two weeks to go,” McCarthy said, offering little clarity on that timeline. While the Treasury Department has predicted the country could breach the debt limit as soon as June 1, the Senate is scheduled to leave Washington in just 10 days, with the House going on a separate recess the week of Memorial Day.

    Schumer described Tuesday as a “bad news and good news” meeting, blasting McCarthy for refusing to rule out default.

    McCarthy dodged reporters’ attempts to get him to promise the nation would make good on its debt, though Senate Minority Leader Mitch McConnell said pointedly: “The United States of America is not going to default.”

    Despite McCarthy suggesting a firm deadline and both parties pooh-poohing the idea of a short-term hike, it remains unclear how seriously negotiators are taking Treasury’s projections of a default as soon as June 1. It took the White House and congressional leaders a week to sit down together after that estimate, and some in Congress are privately wondering whether the debt limit won’t get dealt with until after the Memorial Day holiday.

    “I believe the Treasury secretary when she names the X-date,” House Financial Services Committee Chair Patrick McHenry (R-N.C.) said, referring to the department’s June 1 warning. “I think we have to be prepared to move in anticipation of that date being earlier in the month [of June].”

    McHenry, like McCarthy, said a short-term increase was off the table. But it may be difficult to negotiate a budget deal in time to avoid a debt ceiling breach without more breathing room.

    McConnell essentially backed McCarthy’s position during the meeting and the press availability afterward. Rather than raise alarms, he said the back and forth is normal and Washington is merely “having a debate here” on federal spending “in conjunction with raising the debt ceiling.”

    In the run-up to the meeting, the GOP hardened its position: 43 Republican senators signed on to a letter pledging to filibuster any bill raising the debt ceiling “without substantive spending and budget reforms.” McConnell signed onto that letter and has rhetorically locked arms tightly with McCarthy.

    Biden also has refused to budge from his opposition to negotiations on the debt ceiling. Democrats cite the 2011 debt limit crisis, and the spending cuts and credit downgrades that resulted from that era’s talks with the GOP, as an episode they are unwilling to repeat.

    “People have asked: Will the president give Speaker McCarthy an off-ramp, an exit strategy?” White House press secretary Karine Jean-Pierre said on Tuesday. “The exit strategy is very clear: do your job, Congress must act, prevent a default.”

    House Republicans had generally set low expectations for the meeting, given Democrats’ repeated insistence that they won’t entertain the GOP’s demands. One of the best scenarios possible, as they saw it, was simply that negotiators would agree to a second meeting.

    Some, however, are leaving it to McCarthy to decide what constitutes a win.

    “I’ll let him define that,” Rep. Tom Cole (R-Okla.), chair of the House Rules Committee, said of the speaker after McCarthy departed for the meeting.

    In the meantime, House GOP leaders have no plans to tee up any additional debt measures on the floor. Many privately feel that Biden has more to lose than Republicans, as his approval ratings teeter around 40 percent compared with McCarthy, whose conference has been in lockstep behind him.

    The Senate has not yet voted on the House’s bill or a clean debt ceiling bill introduced by Schumer.

    While both sides prepare to meet again, the parties are expected to keep duking it out in a messaging battle over who would shoulder the blame for the painful effects of a drawn-out debt crisis. That finger-pointing will only grow more tense as financial markets begin to respond to the specter of a potential default.

    The 2011 debt ceiling debacle, which stemmed from Tea Party Republicans pushing the Obama administration for steep spending cuts, ultimately resulted in a downgrade in the country’s credit rating — even after an 11th-hour deal to avoid a default.

    At the time, McConnell swooped in to work with Democrats and then-Vice President Biden to secure a plan they could all swallow. But he has stated clearly that won’t be the case this year: McCarthy is leading the charge this round.

    Adam Cancryn, Sam Stein and Nicholas Wu contributed to this report.

    [ad_2]
    #couldve #worse #White #House #debt #meeting #ends #plans #repeat
    ( With inputs from : www.politico.com )

  • Tucker Carlson to relaunch show on Twitter

    Tucker Carlson to relaunch show on Twitter

    [ad_1]

    “And you know if you bump up against those limits often enough, you will be fired for it,” Carlson said. “That’s not a guess; it’s guaranteed. Every person who works in English language media understands that. The rule of what you can’t say defines everything.”

    Carlson, the former host of “Tucker Carlson Tonight” on Fox News, exited the company after Fox News settled Dominion Voting Systems’ defamation lawsuit for $787.5 million.

    Carlson first joined Fox News as a contributor in 2009, and in 2017, Carlson took over the network’s 8 p.m. hour after Bill O’Reilly was forced out. Carlson was one of the most-watched hosts on the cable news network, with an average audience of 3.2 million viewers.

    Rep. Marjorie Taylor Greene (R-Ga.) took to Twitter to say that she “can’t wait” for Carlson’s new show.

    “The truth will be unstoppable,” Greene said.



    [ad_2]
    #Tucker #Carlson #relaunch #show #Twitter
    ( With inputs from : www.politico.com )

  • Hill reactions: Several Republicans are unfazed by Trump’s sex abuse verdict

    Hill reactions: Several Republicans are unfazed by Trump’s sex abuse verdict

    [ad_1]

    media cnn trump 84673

    The verdict “creates concern,” Sen. Bill Cassidy (R-La.) said, but whether or not it disqualifies the former president from his current presidential bid will be up to the voters.

    But not all Republicans had the same hesitation. Sen. Bill Hagerty (R-Tenn.), who served as ambassador to Japan under Trump, said the verdict was the latest act in the “legal circus” surrounding Trump.

    “I think we’ve seen President Trump under attack since before he became president,” Hagerty said during an interview on Fox News. “This has been going on for years. He’s been amazing in his ability to weather these sorts of attacks and the American public has been amazing in their support through it.”

    “This won’t be the last,” Sen. Tommy Tuberville (R-Ala.), who has endorsed Trump this election cycle, said of the case. “I mean, people are gonna come at him from all angles… People are gonna try and convict him on the papers in Mar-a-Lago. [They] Can’t have him win.”

    The case and the jury were both “a joke,” Sen. Marco Rubio (R-Fla.) said, and Sen. Markwayne Mullin (R-Okla.) said he believes it is “very difficult” for Trump to get a fair trial “in any of these liberal states.”

    House Speaker Kevin McCarthy dodged a question about the verdict during a stakeout with reporters following his meeting with President Joe Biden over the debt limit. Senate Minority Leader Mitch McConnell, Trump’s foe in the chamber, declined to comment, as did Sen. Mike Lee (R-Utah), an ardent supporter of Trump, and Sen. Lindsey Graham (R-S.C.), who has endorsed Trump.

    When it comes to the impact the court’s decision will have on voters, Sen. J.D. Vance (R-Ohio) said he is “highly skeptical” the case will bring Trump down. And Sen. John Cornyn (R-Texas) doesn’t think it will change many minds. “People who love him will still support him and people who don’t, won’t,” Cornyn, a McConnell said, adding that it’s “too early to tell” what the effect will be, if any.

    “He has his due process, and the American people will determine who they want as the leader of this country,” said Rep. Tony Gonzalez (R-Texas), who has endorsed Trump for 2024.

    The ruling comes weeks after the former president was charged with 34 felonies related to the alleged role he played in a scheme to bury accusations of extramarital affairs ahead of the 2016 presidential election. Despite his legal battles, the former president remains the frontrunner for the GOP presidential nomination.

    On Tuesday, Rep. Seth Moulton (D-Mass.) said the former president was “unfit to hold office.”

    “The *front runner* for the Republican nomination for President of the United States has just been found liable for sexual abuse,” Moulton said in a tweet. “The more these lawsuits pile up, the more of an aggrieved version of Trump we’ll get. He is unfit to hold office.”

    Moulton wasn’t alone in noting Trump’s mounting legal battles.

    “Donald Trump — the leader of the Republican Party — has now been impeached twice, indicted, and found liable of sexual abuse and defamation,” Rep. Gerry Connolly (D-Va.) tweeted. “You’ve hitched your wagon to a real stand-up guy, @HouseGOP.”

    First-term Rep. Summer Lee (D-Pa.) also turned the verdict on Republicans, criticizing support for Trump.

    “The Republican party will STILL eagerly stand by him to prop him up while they offer their unwavering support. Their subservience is a slap in the face to survivors and all women,” Lee said on Twitter.

    The former president has been accused of sexual misconduct by more than two dozen women, and in the now infamous “Access Hollywood” tape, he was caught saying that when it comes to women, if you’re a star you can “grab them by the pussy.” Tuesday’s verdict was the first time he has faced legal repercussions for sexual assault.

    Trump defended himself on social media Tuesday afternoon, calling the verdict “a disgrace” and “a continuation of the greatest witch hunt of all time!”

    In a statement, Trump’s campaign called the case “bogus” and said Trump was being targeted because of his position as a frontrunner in the presidential race.

    Daniella Diaz and contributed to this report.



    [ad_2]
    #Hill #reactions #Republicans #unfazed #Trumps #sex #abuse #verdict
    ( With inputs from : www.politico.com )

  • Kari Lake to meet with senators as she inches closer to Senate bid

    Kari Lake to meet with senators as she inches closer to Senate bid

    [ad_1]

    election 2024 cpac 78869

    Lake would likely galvanize Trump supporters to the point that many Republicans think she would be all but impossible to defeat in a primary. But GOP strategists are concerned that Lake would turn off swing voters in the general election, particularly after she contested her loss in the gubernatorial contest in 2022.

    Last year, a number of Senate contenders tied to Trump won their primaries but were defeated in the fall. In an effort to avoid another disappointing election, Sen. Steve Daines (R-Mont.), chair of the NRSC, has actively recruited candidates he believes are electable in key battleground states, including West Virginia, Montana and Pennsylvania. But Daines has not picked a favorite as of yet in Arizona.

    In a CNN interview this week, Senate Minority Leader Mitch McConnell declined to comment directly on a possible run by Lake, though he left Arizona out of his list of top four Senate battlegrounds. He said there is “high likelihood” that GOP leaders would wait until after the primary to determine whether to get involved. “I think there are some other places where with the right candidate, we might be able to compete — in Nevada, Arizona,” he said. The Arizona Senate primary won’t take place until August of 2024.

    The NRSC regularly sits down with potential and declared candidates, and such a meeting does not suggest any preference on its part. Pinal County Sheriff Mark Lamb, the only Republican who has announced a run for Sinema’s seat, had a meeting with the NRSC earlier this year, as did Karrin Taylor Robson, a businessperson who is considering a campaign. Taylor Robson lost to Lake in the 2022 gubernatorial primary.

    Lake’s spokesperson did not provide the names of the senators she is sitting down with this week. The NRSC declined to comment on whether Daines is meeting with Lake. When Lake previously gathered with NRSC officials in February, she did not meet with him.

    Lake and her staffers have taken a number of steps recently that suggest she is either close to running for the Senate or positioning herself as Trump’s running mate, should he win the presidential nomination. Her aide, Colton Duncan, said he is “99 percent sure she’s going to run for Senate.” She is releasing a book, “Unafraid: Just Getting Started.” She has also attacked Gallego as too liberal for Arizona.

    A GOP strategist close to Lake said she is expected to announce a Senate campaign in the early fall, though others in her orbit said a kickoff could take place earlier.

    In addition, Lake has made two stops this year in Iowa, the first-in-the-nation caucus state where she happens to have grown up. Last week, she spoke at Conservative Political Action Conference Hungary and met with Hungarian Prime Minister Viktor Orbán, a venerated international figure in America’s MAGA movement. She is currently in the United Kingdom, where she appeared on “Piers Morgan Uncensored,” speaking to him about her lawsuit disputing her loss in the governor’s race as well as her future.

    “If for some reason we don’t get a fair outcome in our election, I will run for Senate, most likely,” Lake told him.



    [ad_2]
    #Kari #Lake #meet #senators #inches #closer #Senate #bid
    ( With inputs from : www.politico.com )

  • Trump world to donors: A dollar to DeSantis may as well be a donation to Biden

    Trump world to donors: A dollar to DeSantis may as well be a donation to Biden

    [ad_1]

    election 2024 desantis trump 70808

    The memo was sent hours before a New York court delivered a verdict finding that Trump was guilty of sexual abuse of advice columnist E. Jean Carroll and awarding her $5 million in damages for that and defamation.

    Budowich’s memo is, to a degree, a classic boast of a campaign that finds itself in a leading position. He describes Trump as “thoroughly vetted on a national stage” and portrays the legal troubles surrounding the ex-president as fundamentally good for him. “GOP voters aren’t just supporting President Trump overwhelmingly despite the investigations, they are supporting him because of the investigations,” he writes. He also writes that the argument Trump is “not electable” doesn’t hold water with recent polling.

    But the memo is also notable in another respect: underscoring that Team Trump isn’t content to rest on its current lead but eager to keep attacking its main competitors. The memo bashes DeSantis’ Florida legislative session as a “bucket of cold water” for the governor.

    “On top of losing major financial backers and cratering poll numbers, the most memorable part of his legislative session is that he picked a fight with Disney and lost,” Budowich writes. “DeSantis invested tremendous political capital to pass a 6-week abortion ban — in contrast, President Trump maintains a strong pro-life record with exceptions for rape and incest.”

    The memo comes as DeSantis inches closer to making a presidential announcement and as Trump’s team is going after high dollar donors for support — some of whom have publicly wobbled on support for DeSantis or have put their donations on ice until they have a more clear picture of the field. The latest sign that the Florida governor plans to announce soon: DeSantis recently severed ties with his state-level PAC, which has a whopping $86 million, opening the door for that money to be transferred to a pro-DeSantis super PAC supporting his presidential ambitions.

    Last month, Never Back Down, the pro-DeSantis PAC, said it had raised $30 million. The PAC also plans to have staff in the first 18 states on the Republican nominating calendar, according to the AP.

    “While Governor DeSantis tallied up an impressive number of wins for the people of Florida this legislative session, Donald Trump offers the same old, pathetic attacks right out of Nancy Pelosi’s playbook to attempt to diminish the Governor’s conservative success story,” said Erin Perrine, the communications director for Never Back Down in a statement. “Donald Trump blamed the pro-life movement for his endorsed candidates’ losses in the 2022 midterm elections, and states like Trump’s real home, New York, have legalized infanticide up until birth. In Florida, Governor DeSantis has enacted historic measures to defend the dignity of human life and transform Florida into a pro-family state,” she added.

    At the end of 2022, MAGA Inc. reported $54.1 million on hand, and the PAC has spent millions on national cable ads taking direct aim at DeSantis’ record on Medicare and Social Security. The PAC also paid for an eyebrow raising ad that accused DeSantis of “sticking his fingers where they don’t belong” into entitlements. The ad was also a reference to a story about DeSantis using his fingers to eat chocolate pudding on an airplane.

    The MAGA Inc. memo, according to a PAC official, was being circulated on an individual basis Tuesday “to current, past, and targeted donors to MAGA Inc. and like-minded committees” as it “makes a strong push for unity as it looks towards the end for the quarter.”

    After a disappointing midterm election for Republicans, where some important primary races were split over Trump’s endorsement and involvement, the memo calls on donors to rally around one singular Republican candidate to best help 2024 down ballot candidates.

    “The 2024 cycle presents a promising opportunity for Republicans to realize massive gains in the U.S. Senate, House of Representatives, and down ballot races across the nation. Unifying early and focusing our collective resources towards maximizing our gains can be the difference maker,” Budowich writes.

    [ad_2]
    #Trump #world #donors #dollar #DeSantis #donation #Biden
    ( With inputs from : www.politico.com )

  • Florida approves K-12 social studies textbooks after pressing publishers to tweak content

    Florida approves K-12 social studies textbooks after pressing publishers to tweak content

    [ad_1]

    desantis education 61981

    “To uphold our exceptional standards, we must ensure our students and teachers have the highest quality materials available — materials that focus on historical facts and are free from inaccuracies or ideological rhetoric,” Education Commissioner Manny Diaz Jr. said in a statement Tuesday.

    The textbook adoption process for social studies was expected to face intense scrutiny in Florida following the state education agency denying dozens of proposed math textbooks last year for containing “impermissible” content, including lessons on critical race theory.

    Conservatives in Florida, led by DeSantis, have ramped up criticism about what students are reading and learning in school, particularly surrounding race, gender, and sexual orientation through legislation and rulemaking alike. The Republican-dominated Legislature during its 2023 session passed a bill tightening rules for local book objections by requiring schools to yank challenged works within five days of someone flagging it, a shift opponents equate to “book banning.”

    The state is also engaged in a high-profile dispute with the nonprofit College Board after state education department officials rejected its African American studies AP program for initially including coursework on queer theory and intersectionality. The objections angered many Black leaders across the country, with some accusing DeSantis of stoking a cultural fight to boost his presidential aspirations, as the course remains in limbo today.

    Florida as of Tuesday accepted 66 of 101 social studies books submitted by publishers for use in the state, according to the Department of Education. Even with 35 books still pending approval, this marks a major jump from last month when the state initially rejected 81 books for various reasons.

    The agency on Tuesday cited several examples of publishers modifying books after the state flagged them, such as an “inaccurate description of socialism” in one middle school book that claimed the political philosophy “keeps things nice and even and without necessary waste” and “may promote greater equality among people while still providing a fully functioning government-supervised economy.” The publisher stripped that language in a change to the textbook posted by the state.

    The DeSantis administration also spurred one publisher to remove a section in a middle school textbook about “New Calls for Social Justice,” which mentioned the Black Lives Matter movement and Floyd police killing in 2020. This piece of text detailed that “while many American sympathized” with Black Lives Matters, “others charged that the movement was anti-police.”

    Florida determined this content broached “unsolicited topics,” yet critics pan the state’s decision to reject it.

    “Look at the revisions they are celebrating & ask yourself if you trust [Florida] to write our history,” the Florida Freedom to Read Project, an organization that monitors local book challenges, wrote in a tweet.

    DeSantis officials, meanwhile, credited the Florida Department of Education for pushing publishers to rethink their proposals to the state.

    “The political indoctrination of children through the K-12 public education system is a very real and prolific problem in this country,” DeSantis press secretary Bryan Griffin wrote in a tweet Tuesday.



    [ad_2]
    #Florida #approves #K12 #social #studies #textbooks #pressing #publishers #tweak #content
    ( With inputs from : www.politico.com )

  • Jury finds Trump liable for sexual abuse in E. Jean Carroll case

    Jury finds Trump liable for sexual abuse in E. Jean Carroll case

    [ad_1]

    Carroll testified that Trump raped her in a Bergdorf Goodman dressing room after a chance encounter one evening in the spring of 1996. The jury found that Carroll did not prove, by a preponderance of the evidence, that Trump raped her. But the jury did find him liable for sexual abuse and for defamation. The defamation count arose from a statement Trump made last year in which he called Carroll’s allegation a “hoax.”

    “I filed this lawsuit against Donald Trump to clear my name and to get my life back,” Carroll said in a statement after the verdict. “Today, the world finally knows the truth. This victory is not just for me but for every woman who has suffered because she was not believed.”

    Her lawyer, Roberta Kaplan, said the verdict was a triumph for Carroll as well as “for democracy itself, and for all survivors everywhere.”

    “No one is above the law,” she said, “not even a former President of the United States.”

    In a social media post Tuesday, Trump called the verdict “a disgrace.” He added: “a continuation of the greatest witch hunt of all time!”

    Trump lawyer Joe Tacopina said Trump would appeal the verdict. “They rejected the rape claim and they always claimed this was a rape case, so it’s a little perplexing. But we move forward,” Tacopina said.

    He added he had spoken to the former president. “He’s firm in his belief, like many people are, that he cannot get a fair trial in New York City based on the jury pool. And I think one could argue that’s an accurate assessment based on what happened today.”

    Trump did not testify in court and did not even attend the trial. His legal team did not call any witnesses. The case hinged on the testimony of Carroll, who told the jury over the course of three days on the witness stand how her run-in with Trump at the luxury department store turned into a brutal attack in a dressing room in the store’s lingerie department.

    “I’m here because Donald Trump raped me,” Carroll, 79, told the jury. Referring to a book she wrote in which she detailed the alleged incident, she said: “And when I wrote about it, he said it didn’t happen. He lied and shattered my reputation. And I’m here to try to get my life back.”

    In vivid and, at times, tearful testimony, Carroll recounted how Trump shoved her against the dressing room wall, banging her head, and pinned her there with his body weight. She said he then pulled down her tights, inserted his fingers into her vagina and then penetrated her with his penis. The assault lasted a few minutes, she testified, before she managed to free herself and flee the store onto Fifth Avenue.

    She said she contemporaneously disclosed what had happened to two friends, both of whom testified on her behalf, but didn’t tell anyone else about it for more than two decades, when she went public with her account by publishing an excerpt of her book in New York Magazine in 2019.

    Asked if she had stayed quiet for so long because she was worried about how others would react to her story, she rejected that idea. “No, I knew how others would react,” she said. “Women who are raped are looked at as soiled goods. They’re looked at as less.”

    Though jurors never saw Trump in person, they did hear from him in the form of a videotaped deposition, footage from a presidential debate and campaign rallies, and the “Access Hollywood” tape, a recording from 2005 in which Trump, caught on a hot mic, boasted that when it comes to women, if you’re a star you can “grab them by the pussy.”

    In his deposition, Trump denied having raped Carroll or even knowing her, calling her allegation “the most ridiculous, disgusting story.”

    “It’s just made up,” he said.

    His lawyers, meanwhile, argued that Carroll’s testimony wasn’t credible, largely because Carroll couldn’t pinpoint certain pieces of information, including the precise date of the alleged attack. And they questioned other aspects, such as her claim that she didn’t recall seeing any other shoppers or sales attendants during the encounter at Bergdorf’s.

    Carroll’s attorneys leaned heavily on the “Access Hollywood” tape, arguing that it amounted to “a confession,” as one of them put it, that Trump had a habit of sexually assaulting women and that he relied on a playbook of sorts to do so. To bolster that argument, her attorneys called two other Trump accusers as witnesses: Jessica Leeds and Natasha Stoynoff.

    The nine-person jury delivered its unanimous – as required by law – verdict after an eight-day trial. Jurors in the case remained anonymous throughout the trial — even to Carroll, Trump and their lawyers — after U.S. District Judge Lewis Kaplan ordered that their identities be kept secret due to “a very strong risk that jurors will fear harassment.”

    Though the statute of limitations had long expired on Carroll’s battery claim, she was able to sue Trump under a New York state law that opened a one-year window beginning in November 2022 during which people can sue their alleged abusers for sexual assault.

    For Carroll, the courtroom experience was bittersweet. Asked during her testimony whether she was glad she spoke out against Trump, she broke into tears.

    “I’ve regretted this about 100 times,” she said, pausing. “But in the end, being able to get my day in court, finally, is everything to me,” she said, her speech interrupted by crying. “So I’m happy.”

    [ad_2]
    #Jury #finds #Trump #liable #sexual #abuse #Jean #Carroll #case
    ( With inputs from : www.politico.com )

  • Feinstein returning to D.C. as debt limit fight heats up

    Feinstein returning to D.C. as debt limit fight heats up

    [ad_1]

    dianne feinstein 74716

    Her travel back to Washington follows a conversation last week with Senate Majority Leader Chuck Schumer, in which she said she could return as soon as this week. It is not yet clear if Feinstein will participate in Tuesday night’s floor votes.

    “I’m glad that my friend Dianne is back in the Senate and ready to roll up her sleeves and get to work. After talking with her multiple times over the past few weeks, it’s clear she’s back where she wants to be and ready to deliver for California,” Schumer said in a statement Tuesday.

    Feinstein’s return will put two nominees in the spotlight, in part because Feinstein’s absence is not the only vote holding them up. Senate Democrats will now have to grapple with the nomination of Michael Delaney for the First Circuit, which has been held over in Judiciary for weeks and could face further problems on the floor. Delaney faces criticism, even from some Democrats, over his representation of a school in a sexual assault case.

    Feinstein’s vote could also be critical for Julie Su, President Joe Biden’s pick for Secretary of Labor. A handful of moderate Democrats, including Sens. Joe Manchin (D-W.Va.) and Jon Tester (D-Mont.) have declined to say whether they will support her on the floor. Any Democratic defections would make Feinstein’s vote even more critical in the 51-49 Senate.

    [ad_2]
    #Feinstein #returning #D.C #debt #limit #fight #heats
    ( With inputs from : www.politico.com )

  • Kashmir’s AIIMS Scientist Leads Major Cancer Breakthrough

    [ad_1]

    by Faiqa Masoodi

    SRINAGAR: In a major breakthrough, a Kashmiri scientist along with a group of European scientists has discovered a new potential drug for the treatment of metastatic hypoxic cancers. The drug is currently in an advanced stage of further investigations post-animal trials.

    Dr Musadir Nabi Peerzada
    Dr Musadir Nabi Peerzada (AIIMS)

    Hailing from Muqami Shahwali in Kupwara’s Drugmulla belt, Dr Mudasir Nabi Peerzada led a team of eminent European scientists and co-workers to discover a new drug for the treatment of various metastatic hypoxic cancers.

    Dr Peerzada who is currently working as a C-Level scientist at AIIMS New Delhi, has completed his postdoctoral training at the National Institute of Pathology. He was awarded a prestigious postdoctoral fellowship by the Indian Council of Medical Research (ICMR), Department of health research, Government of India.

    The discovery is believed to help in silencing the HIF-1 factor-controlled human CAIX and CAXII activity in cancerous cells. The hCAIX and hCAXII are overexpressed in the renal, pancreatic, gut, oral, brain, lung, and ovarian cancers, therefore the drug could be significant in treating multiple cancers with greater efficacy.

    Dr Mudasir said that he and his team strenuous efforts for many years to make this path-breaking discovery. The drug has shown satisfactory results in various tumour models and is currently undergoing advanced investigations.

    “This discovery took us years of tests and trials. We tested it on animals before going ahead,” Dr Peerzada said, adding that the drug is undergoing advanced clinical trials for further investigation.

    The study was published in ACS Medicinal Chemistry Letters entitled Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors was published on May 8, 2023.

    He said that the new findings are remarkable in curing hypoxic cancers and will be a boon for cancer-related research.

    The other scientists who are part of this invention include Dr Alessandro Bonardi, Dr Niccolò Paoletti, Dr Daniela Vullo, Dr Paola Gratteri, Dr Claudiu T Supuran, and Dr Amir Azam

    Dr Peerzada is working on the development of anti-cancer therapeutics discovery taking into account the ATP binding site of kinases, hCAIX, hCAXII activity, cycle arrest at the G2/M phase of mitosis, prevention of HER2 dimerisation to deregulate PI3K/AKT and MAPK cell signalling pathways.

    [ad_2]
    #Kashmirs #AIIMS #Scientist #Leads #Major #Cancer #Breakthrough

    ( With inputs from : kashmirlife.net )

  • Feds turn antitrust focus to digital pharma ads

    Feds turn antitrust focus to digital pharma ads

    [ad_1]

    ftc frontier lawsuit 84453

    At issue in the FTC probe is whether the deal would help IQVIA, a $35 billion pharmaceutical data and analytics company, lock up the bulk of the market for digital advertising of pharmaceuticals aimed at doctors and patients, thereby harming rivals and potentially increasing costs for drugmakers, said three of the people, who were granted anonymity to discuss a confidential investigation. IQVIA is already the largest player in health data and analytics.

    The FTC is nearing the end of its investigation, and staff lawyers reviewing the deal are leaning toward filing a lawsuit to block it, according to two of the people. No final decision has been made, and the agency could ultimately choose to not bring a case.

    “There are many companies — from very large, well-known companies (e.g., Google, Microsoft/Xandr, WebMD) to smaller recent entrants — providing technology, data, and services to support digital advertising from life science companies to doctors and patients,” IQVIA spokesperson Trent Brown said. “IQVIA began providing some of these services only in the past few years, and the DeepIntent business will fill a gap in IQVIA’s offerings by adding a demand-side platform.”

    Brown said the company will continue working with the FTC to clear the deal.

    A DeepIntent spokesperson did not respond to a request for comment. A FTC spokesperson declined to comment.

    IQVIA is the leading provider of pharmaceutical sales and reference data, and also sells software for analyzing that information. Drug companies use IQVIA’s trove of information — which includes over 800 million de-identified patient records and petabytes of sales, promotional and prescription data — to gauge the likely demand for the drugs they’re developing and accurately compensate their sales forces. Generic drug companies, for example, can use the data to determine if it is financially feasible to introduce a competitor to a branded drug.

    DeepIntent is a privately held advertising technology company that works with pharmaceutical companies to market drugs to doctors and patients. It also helps client companies measure and improve the success of those ad campaigns.

    IQVIA made multiple moves in 2022 to build out an advertising business, including the separate purchase of Lasso Marketing, another health care ad tech company.

    The FTC is investigating both the combination of the two direct competitors — Lasso and DeepIntent — as well as so-called “vertical” concerns of whether IQVIA would be able to leverage its mountain of pharmaceutical sales data to monopolize the pharmaceutical advertising market, three of the people said.

    In its most recent annual report, IQVIA said the scope of its data covers more than 85 percent of the world’s pharmaceuticals. That includes “more than 1.2 billion comprehensive, longitudinal, non-identified patient records spanning sales, prescription and promotional data, medical claims, electronic medical records, genomics, and social media” from around 150,000 data suppliers.

    Pharmaceutical advertising is big business. The total U.S. market for pharma ads is at least $11.5 billion, based on data collected by advertising analytics company Standard Media Index. Darrick Li, SMI’s vice president of sales in North America said anecdotal evidence could put that number as high as $15 billion. Of that, he said, around 53 percent (roughly $8 billion at the high estimate) is digital, which is growing at a rapid 17 percent clip, in the first quarter of 2023 compared to the year-earlier period, Li said.

    And while the pharmaceutical industry has been slow to evolve from traditional television ads, the digital shift is happening, and that’s where companies like DeepIntent come in. According to industry participants, it is one of a handful of companies helping drugmakers target ads at both doctors and patients. Last year the company said it could offer guarantees on the number of verified patients reached.

    In targeting ads at doctors, IQVIA is already a key supplier of data to DeepIntent.

    Part of the FTC investigation is focused on how the deal could pose a threat to competing ad platforms serving the pharmaceutical industry including The Trade Desk, which uses IQVIA data, as well as Pulse Point, according to three of the people with knowledge of the investigation. Those companies help advertisers, including drugmakers, place ads around the internet. The latter is owned by Internet Brands, which also owns WebMD and Medscape, an informational service for health care providers.

    The FTC is concerned that with both DeepIntent and Lasso, the bulk of these ads will run through IQVIA, those people said. Those ads show up on health care-focused websites used by doctors, and general websites across the internet.

    Spokespeople for The Trade Desk and Pulse Point did not respond for comment.

    The FTC is also focused on IQVIA’s ability to control the market for services that measure the success of digital advertising campaigns. IQVIA offers this service, as do companies including Veeva Systems and PurpleLab. Those companies can currently measure the success of advertising campaigns run by DeepIntent, but if the merger goes through, the FTC is concerned IQVIA would make it more difficult for them to do so, according to three of the people.

    Spokespeople for Veeva and PurpleLab did not respond for comment.

    “Does this give IQVIA the incentive and ability to withhold the data or raise prices to people who access it today? If the answer to that is ‘yes,’ then maybe there’s an antitrust issue here,” a health care lawyer said on the condition of anonymity, due to client conflicts.

    The FTC is concerned with exactly that scenario, the people said.

    However, at least one ad tech expert disagrees.

    “IQVIA in this case is just buying a revenue stream,” said Augustine Fou, a digital advertising consultant who advises companies including drugmakers. “They are unlikely to turn away revenue from selling data if other companies are willing to pay for it. While it’s possible that IQVIA could favor its own platform, for example by only selling outdated data to competitors, that would be difficult to prove before it happened.”

    When a company controls a key input used by its competitors — in this case pharmaceutical sales data — it only works to withhold that data from rivals if it facilitates a price increase that would justify the lost revenue.

    In this case, Fou said IQVIA would be unlikely to recoup its losses by raising prices for its advertising services. And even though DeepIntent’s lower data costs post-merger would allow it to theoretically undercut its rivals on price, it would take years to get advertisers and agencies to switch to DeepIntent, even with prolonged, deeply discounted pricing, because of long-term contracts, Fou said.

    IQVIA is no stranger to antitrust scrutiny or the FTC. The company was previously investigated by the agency’s lawyers for how it bundles various products, and its unwillingness to allow competing software companies to access its data. The related FTC investigation, first reported by The Capitol Forum, did not result in an enforcement action.

    Antitrust enforcers in recent years have been wading deeply into the complex world of digital advertising, primarily targeting Google, which was sued by the Justice Department in January over allegations it has illegally monopolized the market.

    Within the greater world of programmatic advertising, DeepIntent is a relatively small player. However, specializing in health care gives it an edge in its specific niche over larger players. For example, Google allows pharmaceutical companies to run search ads and place ads in health care-focused websites. However, the platform does not allow advertisers to target consumers based on health information and also cannot target doctors directly.

    A Google spokesperson declined to comment.

    Google’s leading position in the overall digital ad market is not a factor in the FTC’s investigation, according to three of the people with knowledge of the probe.

    [ad_2]
    #Feds #turn #antitrust #focus #digital #pharma #ads
    ( With inputs from : www.politico.com )